Mark Kupersmith, MD
img_Mark Kupersmith
CLINICAL PROFESSOR | Ophthalmology
CLINICAL PROFESSOR | Neurology
CLINICAL PROFESSOR | Neurosurgery
Research Topics
MRI, Neuroscience, Vision
New topic

I have serve as Chair of the planning committee for NORDIC and directed NORDIC (February 2009-present), fulfilling all of the obligations outlined in NORDIC policies and in the Idiopathic Intracranial Hypertension Treatment Trial, the LIIHTT and for proposed studies, HIS and SiihTT. I intend to continue in the same capacity now as Director of the Enrollment and Resource Centers, administratively integrating studies, sites, investigators, reading centers, Data Coordinating and Biostatistical Center, managing sites and committees and overseeing finance, and scientifically contributing to the multi-site studies conducted across the US and Canada by NORDIC (Neuro-Ophthalmology Research Disease Investigator Consortium).

 

I direct an ECRIP center award at NYEEI, title 'Noninvasive optical imaging detection of changes in the peripapillary retina and optic nerve head due to damage of the optic nerve' which is currently studying glaucoma, optic neuritis, NAION, giant cell arteritis, and NMO. Each project is headed by a 'fellow' who are all subspecialty trained ophthalmologists or neurologists.

New award

Publications

Selected Publications

A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. Leonard A. Levin, M. Tariq Bhatti, Sharon Klier, Rachelle Morgenstern, David Szanto, Neil R. Miller, Mark J. Kupersmith, Clare Fraser, Celia Chen, Neil Shuey, Stephen Colley, Ningli Wang, Hongliang Dou, Yong Zhong, Luosheng Tang, Quanhong Han, Gamulescu Maria-Andreea, Nicole Eter, Helmut Wilhelm, Lorenz Katrin, Krishna G. Santhosh, Ramesh Kekunnaya, S. Ambika, Kumudini Sharma, Vivekanand Uttamrao Warkad, Rohit Saxena, Kumar S. Mahesh, Das Dipankar Sri Sankara Dev Nethralaya, Atul Hegade, Shahana Mazumdar, Sachin Daighavane, Virender Sachdeva, Hadas Kalish, Ainat Klein, Ruth Huna-Baron, Goldenberg Cohen Nitza, Marina Shneck, Joshua Kruger, Antonio Pasquale Ciardella, Gianni Virgili, Arturo Carta, Stefania Bianchi Marzoli, Sharon Tow, Chin Chee Fang, Peter MacIntosh, Jeffrey Bennett, Byron Lam, Bradley Katz, Zoe Williams, Michael Lee, Madhura Tamhankar, Rudrani Banik, Michael Rauser, Marc Levy, Yaping Joyce Liao, James Luu, Michael Tibbetts, David Scales, Robert Lesser, Anil Patel, Syndee Givre, Van Stavern Gregory, Steven Hamilton, Vivian Rismondo, Courtney Francis, Dean Cestari, Marc Dinkin, John Pula, Padmaja Sudhakar, Steven Newman, Rosa Tang, Joseph Chacko, Sachin Kedar, Peter Quiros, Larry Frohman, Nicholas Volpe, Patrick Sibony, John Chen, Luis Mejico, Gregory Kosmorsky, Alfaro Daniel Virgil, David Katz, Andrew Lee, Lindsey DeLott, Vivek Patel, Swaraj Bose, Crandall Peeler, Tariq Bhatti, Dirk Sandner, Hana Leiba. Ophthalmology

Multimodal Deep Learning Differentiates Papilledema and Non-Arteritic Anterior Ischemic Optic Neuropathy From Healthy Eyes. David Szanto, Asala Erekat, Brian Woods, Jui Kai Wang, Mona Garvin, Brett Johnson, Randy Kardon, Michael Wall, Edward Linton, Mark J. Kupersmith. Investigative Ophthalmology and Visual Science

Automated Retinal Vascular Analysis Reveals Response to Acetazolamide in Idiopathic Intracranial Hypertension. Brian Woods, David Szanto, Jui Kai Wang, Asala Erekat, Lola Stern, Aaron Golden, Mona K. Garvin, Randy H. Kardon, Mark J. Kupersmith. Translational Vision Science and Technology

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kupersmith during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Founder/Co-Founder/Partner

  • SafeTherapeutics, LLC

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.